BIOMAT Database Logo BIOMAT Database Logo

Hepatosplenic gammadelta T-cell lymphoma in a 10-year-old boy successfully treated with hematopoietic stem cell transplantation. 2004

Adam Gassas, and Melanie Kirby, and Sheila Weitzman, and Bo Ngan, and Oussama Abla, and John J Doyle
Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Ontario, Canada. adam.gassas@sickkids.ca

The authors report a 10-year-old boy with hepatosplenic gammadelta T-cell lymphoma, a rare form of lymphoma that is highly aggressive, exceedingly rare in children, and primarily seen in young men. Conventional multi-agent chemotherapy appears to be inadequate for cure. This is the first report with this type of lymphoma in a boy less than 15 years old treated with hematopoietic stem cell transplantation (HSCT).

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013160 Splenic Neoplasms Tumors or cancer of the SPLEEN. Cancer of Spleen,Spleen Cancer,Cancer of the Spleen,Neoplasms, Splenic,Spleen Neoplasms,Splenic Cancer,Cancer, Spleen,Cancer, Splenic,Cancers, Spleen,Cancers, Splenic,Neoplasm, Spleen,Neoplasm, Splenic,Neoplasms, Spleen,Spleen Cancers,Spleen Neoplasm,Splenic Cancers,Splenic Neoplasm
D016399 Lymphoma, T-Cell A group of heterogeneous lymphoid tumors representing malignant transformations of T-lymphocytes. T-Cell Lymphoma,Lymphoma, T Cell,Lymphomas, T-Cell,T Cell Lymphoma,T-Cell Lymphomas
D016692 Receptors, Antigen, T-Cell, gamma-delta T-cell receptors composed of CD3-associated gamma and delta polypeptide chains and expressed primarily in CD4-/CD8- T-cells. The receptors appear to be preferentially located in epithelial sites and probably play a role in the recognition of bacterial antigens. The T-cell receptor gamma/delta chains are separate and not related to the gamma and delta chains which are subunits of CD3 (see ANTIGENS, CD3). Antigen Receptors, T-Cell, gamma-delta,T-Cell Receptors delta-Chain,T-Cell Receptors gamma-Chain,T-Cell Receptors, gamma-delta,TcR gamma-delta,Antigen T Cell Receptor, delta Chain,Antigen T Cell Receptor, gamma Chain,Receptors, Antigen, T Cell, gamma delta,T Cell Receptors, gamma delta,T-Cell Receptor delta-Chain,T-Cell Receptor gamma-Chain,T-Cell Receptor, gamma-delta,T Cell Receptor delta Chain,T Cell Receptor gamma Chain,T Cell Receptor, gamma delta,T Cell Receptors delta Chain,T Cell Receptors gamma Chain,TcR gamma delta,delta-Chain, T-Cell Receptor,delta-Chain, T-Cell Receptors,gamma-Chain, T-Cell Receptor,gamma-Chain, T-Cell Receptors,gamma-delta T-Cell Receptor,gamma-delta T-Cell Receptors,gamma-delta, TcR
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D033581 Stem Cell Transplantation The transfer of STEM CELLS from one individual to another within the same species (TRANSPLANTATION, HOMOLOGOUS) or between species (XENOTRANSPLANTATION), or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS). The source and location of the stem cells determines their potency or pluripotency to differentiate into various cell types. Transplantation, Stem Cell,Stem Cell Transplantations,Transplantations, Stem Cell

Related Publications

Adam Gassas, and Melanie Kirby, and Sheila Weitzman, and Bo Ngan, and Oussama Abla, and John J Doyle
Allogeneic stem cell transplantation for hepatosplenic gammadelta T-cell lymphoma.
March 2007, Leukemia & lymphoma,
Adam Gassas, and Melanie Kirby, and Sheila Weitzman, and Bo Ngan, and Oussama Abla, and John J Doyle
Hepatosplenic gammadelta T-cell lymphoma successfully treated with a combination of alemtuzumab and cladribine.
May 2008, Annals of oncology : official journal of the European Society for Medical Oncology,
Adam Gassas, and Melanie Kirby, and Sheila Weitzman, and Bo Ngan, and Oussama Abla, and John J Doyle
Refractory hepatosplenic T-cell lymphoma was successfully treated with salvage allogeneic hematopoietic stem cell transplantation combined with enhanced myeloablative preconditioning.
January 2023, Annals of hematology,
Adam Gassas, and Melanie Kirby, and Sheila Weitzman, and Bo Ngan, and Oussama Abla, and John J Doyle
A case of hepatosplenic T-cell lymphoma successfully treated by HLA haploidentical stem cell transplantation.
June 2020, Journal of clinical and experimental hematopathology : JCEH,
Adam Gassas, and Melanie Kirby, and Sheila Weitzman, and Bo Ngan, and Oussama Abla, and John J Doyle
Hepatosplenic gammadelta T-cell lymphoma.
June 2005, World journal of gastroenterology,
Adam Gassas, and Melanie Kirby, and Sheila Weitzman, and Bo Ngan, and Oussama Abla, and John J Doyle
Hepatosplenic alphabeta T-cell lymphoma successfully treated with allogeneic bone marrow transplantation.
April 2007, Bone marrow transplantation,
Adam Gassas, and Melanie Kirby, and Sheila Weitzman, and Bo Ngan, and Oussama Abla, and John J Doyle
Hepatosplenic gammadelta-T-cell lymphoma with leukemic course after renal transplantation.
February 2002, Human pathology,
Adam Gassas, and Melanie Kirby, and Sheila Weitzman, and Bo Ngan, and Oussama Abla, and John J Doyle
[A case of hepatosplenic gammadelta T cell lymphoma].
June 2005, Zhongguo shi yan xue ye xue za zhi,
Adam Gassas, and Melanie Kirby, and Sheila Weitzman, and Bo Ngan, and Oussama Abla, and John J Doyle
Hepatosplenic gammadelta T cell lymphoma: a diagnostic pitfall.
September 2003, Journal of hepatology,
Adam Gassas, and Melanie Kirby, and Sheila Weitzman, and Bo Ngan, and Oussama Abla, and John J Doyle
Hepatosplenic gammadelta T-cell lymphoma: A case report.
May 2007, European journal of internal medicine,
Copied contents to your clipboard!